Loading company
Loading
Open Financials Bionano Genomics, Inc. (BNGO) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $28.5 million | $30.8 million | -7.4% | 10-K 2026-03-23 · proof |
| Gross profit | $13.2 million | $380,000 | +3,369.7% | 10-K 2026-03-23 · proof |
| Operating income | -$33.3 million | -$104 million | 10-K 2026-03-23 · proof | |
| Net income | -$26.4 million | -$112 million | 10-K 2026-03-23 · proof |
- What was Bionano Genomics, Inc. (BNGO)'s revenue in fiscal 2025?
- Bionano Genomics, Inc. (BNGO) reported revenue of $28.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $30.8 million the year before (-7.4%). Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
- What was Bionano Genomics, Inc. (BNGO)'s gross profit in fiscal 2025?
- Bionano Genomics, Inc. (BNGO) reported gross profit of $13.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $380,000 the year before (+3,369.7%). Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
- What was Bionano Genomics, Inc. (BNGO)'s operating income in fiscal 2025?
- Bionano Genomics, Inc. (BNGO) reported operating income of -$33.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$104 million the year before. Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
- What was Bionano Genomics, Inc. (BNGO)'s net income in fiscal 2025?
- Bionano Genomics, Inc. (BNGO) reported net income of -$26.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$112 million the year before. Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BNGO&period_type=annual&limit=5"Information only, not investment advice.